595 related articles for article (PubMed ID: 6488167)
21. Comparative benzo[a]pyrene metabolite patterns in fish and rodents.
Melius P
Natl Cancer Inst Monogr; 1984 May; 65():387-90. PubMed ID: 6087145
[TBL] [Abstract][Full Text] [Related]
22. Hepatic metabolism of 7,12-dimethylbenz(a)anthracene in male, female, and ovariectomized Sprague-Dawley rats.
Vater ST; Baldwin DM; Warshawsky D
Cancer Res; 1991 Jan; 51(2):492-8. PubMed ID: 1898712
[TBL] [Abstract][Full Text] [Related]
23. Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration.
Foth H; Mollière M; Kahl R; Jähnchen E; Kahl GF
Drug Metab Dispos; 1984; 12(6):760-6. PubMed ID: 6150827
[TBL] [Abstract][Full Text] [Related]
24. Effect of microsomal enzyme inducers on the urinary excretion pattern of mutagenic metabolites of the carcinogen 2,4-toluenediamine.
Reddy TV; Ramanathan R; Benjamin T; Grantham PH; Weisburger EK
J Natl Cancer Inst; 1986 Feb; 76(2):291-7. PubMed ID: 3456067
[TBL] [Abstract][Full Text] [Related]
25. A comparison of avian and rodent S-9 liver homogenates in the Ames test.
Rosanoff KA; Jones DH; Sawyer TW
Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):131-9. PubMed ID: 6328598
[TBL] [Abstract][Full Text] [Related]
26. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
[No Abstract] [Full Text] [Related]
27. Identification of mutagenic metabolites of indeno[1,2,3-cd]pyrene formed in vitro with rat liver enzymes.
Rice JE; Coleman DT; Hosted TJ; LaVoie EJ; McCaustland DJ; Wiley JC
Cancer Res; 1985 Nov; 45(11 Pt 1):5421-5. PubMed ID: 4053016
[TBL] [Abstract][Full Text] [Related]
28. 6-Nitrobenzo[a]pyrene can be denitrated during mammalian metabolism.
Raha C; Hart-Anstey M; Cheung MS; Bresnick E
J Toxicol Environ Health; 1986; 19(1):55-64. PubMed ID: 3746941
[TBL] [Abstract][Full Text] [Related]
29. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
[TBL] [Abstract][Full Text] [Related]
30. Intestinal bioavailability and biotransformation of 3-hydroxybenzo(a)pyrene in an isolated perfused preparation from channel catfish, Ictalurus punctatus.
James MO; Tong Z; Rowland-Faux L; Venugopal CS; Kleinow KM
Drug Metab Dispos; 2001 May; 29(5):721-8. PubMed ID: 11302939
[TBL] [Abstract][Full Text] [Related]
31. Formation of mutagenic metabolites from benzo(a)pyrene and 2-aminoanthracene by the s-9 fraction from the liver of the Northern pike (Esox lucius): inducibility with 3-methylcholanthrene and correlation with benzo[a]pyrene monooxygenase activity.
Balk L; Depierre JW; Sundvall A; Rannug U
Chem Biol Interact; 1982 Jul; 41(1):1-13. PubMed ID: 6284388
[TBL] [Abstract][Full Text] [Related]
32. Identification of etoposide glucuronide as a major metabolite of etoposide in the rat and rabbit.
Hande K; Anthony L; Hamilton R; Bennett R; Sweetman B; Branch R
Cancer Res; 1988 Apr; 48(7):1829-34. PubMed ID: 3349461
[TBL] [Abstract][Full Text] [Related]
33. The metabolism of oestrone and some other steroids in isolated perfused rat and guinea pig livers.
Roy AB; Curtis CG; Powell GM
Xenobiotica; 1987 Nov; 17(11):1299-313. PubMed ID: 2963441
[TBL] [Abstract][Full Text] [Related]
34. Benzo(a)pyrene oxidation, conjugation and disposition in the isolated perfused rabbit lung: role of the glutathione S-transferases.
Ball LM; Plummer JL; Smith BR; Bend JR
Med Biol; 1979 Oct; 57(5):298-305. PubMed ID: 522517
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of benzo[a]pyrene in the perfused rat liver: factors affecting the release of phenolic metabolites into the bile and perfusate.
Sweeny DJ; Reinke LA
Carcinogenesis; 1987 Jun; 8(6):779-83. PubMed ID: 3608074
[TBL] [Abstract][Full Text] [Related]
36. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
[TBL] [Abstract][Full Text] [Related]
37. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
38. Release of mutagenic metabolites of benzo[a]pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide.
Bock KW; Bock-Hennig BS; Lilienblum W; Volp RF
Chem Biol Interact; 1981 Aug; 36(2):167-77. PubMed ID: 6268312
[TBL] [Abstract][Full Text] [Related]
39. Metabolism and excretion of benzo(a)pyrene 4,5-oxide by the isolated perfused rat liver.
Smith BR; Bend JR
Cancer Res; 1979 Jun; 39(6 Pt 1):2051-6. PubMed ID: 445404
[TBL] [Abstract][Full Text] [Related]
40. Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites.
Zenser TV; Lakshmi VM; Davis BB
Drug Metab Dispos; 1999 Sep; 27(9):1064-7. PubMed ID: 10460807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
